23.65
전일 마감가:
$23.66
열려 있는:
$23.7499
하루 거래량:
642
Relative Volume:
0.28
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-1.13%
1개월 성능:
-1.46%
6개월 성능:
-1.42%
1년 성능:
-4.64%
Lifemd Inc Stock (LFMDP) Company Profile
명칭
Lifemd Inc
전화
866 351 5907
주소
236 Fifth Avenue, Suite 400, New York
Compare LFMDP vs HITI, PETS, POM, SCNX, HKPD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
LFMDP
Lifemd Inc
|
23.65 | 0 | 0 | 0 | 0 | 0.00 |
|
HITI
High Tide Inc
|
2.45 | 214.47M | 452.61M | -35.30M | 13.25M | -0.3863 |
|
PETS
Petmed Express Inc
|
2.30 | 47.94M | 182.67M | -64.87M | -22.92M | -3.1193 |
|
POM
Pomdoctor Ltd Adr
|
0.3801 | 45.29M | 0 | 0 | 0 | 0.00 |
|
SCNX
Scienture Holdings Inc
|
0.4012 | 15.89M | 653.40K | -20.19M | -11.11M | -1.8091 |
|
HKPD
Cellyan Biotechnology Co Ltd
|
0.685 | 14.69M | 0 | 0 | 0 | 0.00 |
Lifemd Inc 주식(LFMDP)의 최신 뉴스
Earnings Preview: LifeMD to Report Financial Results Post-market on May 06 - Moomoo
[DEF 14A] LifeMD, Inc. Definitive Proxy Statement - Stock Titan
LifeMD (LFMD) soars 23.7%: Is further upside left in the stock? - MSN
LifeMD (LFMD) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
LifeMD to Report First Quarter 2026 Financial Results on May 6 - The Manila Times
After the bell May 6: LifeMD sets Q1 results call for 4:30 p.m. ET - Stock Titan
LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates - MSN
LFMD (LifeMD Inc.) shares rise nearly four percent after Q4 2025 earnings narrowly miss analyst consensus estimates. - Cổng thông tin điện tử Tỉnh Sơn La
LifeMD (LFMD) Stock: Complete Guide (+3.53%) 2026-04-22Safe Entry Stocks - UBND thành phố Hải Phòng
Analysts Expect Breakeven For LifeMD, Inc. (NASDAQ:LFMD) Before Long - Moomoo
LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock? - Yahoo Finance
LifeMD (LFMD) Stock: Resistance Rejection Signals (Momentum Building) 2026-04-20Crowd Sentiment Stocks - Cổng thông tin điện tử Tỉnh Sơn La
Is LifeMD (LFMD) stock testing breakout levels (Overhead Buying) 2026-04-18Continuation Signals - Xã Vĩnh Công
How The LifeMD (LFMD) Story Is Shifting Around GLP-1 Growth Plans And 2026 Expectations - Yahoo Finance
JPMorgan Chase & Co. Has $414,000 Stock Holdings in LifeMD, Inc. $LFMD - MarketBeat
Hims & Hers Powers Patient-Provider Connectivity via Digital Platforms - TradingView
LifeMD, Inc. (NASDAQ:LFMD) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Breakout Zone: Is LifeMD Inc gaining market share2026 Catalysts & Real-Time Volume Trigger Notifications - baoquankhu1.vn
LifeMD adds Eli Lilly’s oral weight loss drug to platform By Investing.com - Investing.com Canada
LifeMD adds Eli Lilly’s oral weight loss drug to platform - Investing.com
LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management - ChartMill
Dividend Watch: How sensitive is LifeMD Inc to inflation2026 Price Targets & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
LifeMD (NASDAQ:LFMD) Trading Down 4.2%What's Next? - MarketBeat
Big Money Moves: Why is LifeMD Inc stock going up2026 Market Outlook & Fast Moving Stock Trade Plans - baoquankhu1.vn
LFMD Technical Analysis & Stock Price Forecast - intellectia.ai
LifeMD, Inc. (LFMD) Stock Analysis: Exploring A Potential 181.34% Upside In Telehealth - DirectorsTalk Interviews
LifeMD Earnings Call Highlights Aggressive Growth Push - TipRanks
LifeMD, Inc. (LFMDP) Stock Price, News, Quote & History - Yahoo! Finance Canada
LFMDP SEC FilingsLifemd, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
200,000 LifeMD (LFMD) RSUs awarded to marketing head - Stock Titan
[Form 3] LifeMD, Inc. Initial Statement of Beneficial Ownership - Stock Titan
LifeMD (LFMD) CFO Atul Kavthekar listed as reporting person in Form 3 - Stock Titan
Mizuho Upgrades LifeMD (LFMD) with Raised Price Target to $8.00 - GuruFocus
LifeMD launches Wegovy subscription program with Novo Nordisk By Investing.com - Investing.com South Africa
LifeMD Offers Novo Nordisk's Industry-First Wegovy Telehealth Subscription Program - Bitget
Slash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription Plan - Benzinga
NVO: Novo Nordisk's Wegovy Subscription Program Launches with Li - GuruFocus
LifeMD launches Wegovy subscription program with Novo Nordisk - Investing.com
LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program - marketscreener.com
Novo to sell Wegovy subscriptions on Hims, LifeMD, and others - seekingalpha.com
Up to $1,200 off Wegovy: LifeMD launches Novo telehealth plan - Stock Titan
Earnings Miss: Why is LifeMD Inc stock going up2026 Risk Factors & Breakout Confirmation Trade Signals - baoquankhu1.vn
LifeMD’s GLP-1 Growth Looks Real, But The Stock’s Still Cheap - Finimize
LifeMD Offers Novo Nordisk’s Ozempic For $499 A Month To Eligible Patients - MSN
LifeMD: Comparing The High Yield Preferred Stock To An Options Income Strategy (LFMD) - Seeking Alpha
LifeMD, Inc. 8.875% CUM PFD A declares $0.5547 dividend - MSN
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - Sahm
How Lifemd Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) Affects Rotational Strategy Timing - Stock Traders Daily
Lifemd Inc (LFMDP) 재무 분석
Lifemd Inc (LFMDP)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):